Overview
Akira Shimotoyodome practices practicing medicine in Tochigi, Japan.
Their clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Obesity.
They are actively involved in clinical research, co-authoring 45 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Akira Shimotoyodome
Is Akira Shimotoyodome a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Akira Shimotoyodome is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Akira Shimotoyodome participate in research or clinical trials?
Yes. Akira Shimotoyodome has published 45 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Akira Shimotoyodome's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- ObesityShimotoyodome isExperienced. Learn about Obesity.
- Primary Lateral SclerosisShimotoyodome isExperienced. Learn about Primary Lateral Sclerosis.